User talk:Kevinzhang131

Welcome!
Hello, Kevinzhang131, and welcome to Wikipedia! Thank you for your contributions. I hope you like the place and decide to stay. Here are a few links to pages you might find helpful: Please remember to sign your messages on talk pages by typing four tildes ( ~ ); this will automatically insert your username and the date. If you need help, check out Questions, ask me on my talk page, or ask your question on this page and then place  before the question. Again, welcome! BracketBot (talk) 04:26, 8 July 2014 (UTC)
 * Introduction and Getting started
 * Contributing to Wikipedia
 * The five pillars of Wikipedia
 * How to edit a page and How to develop articles
 * How to create your first article
 * Simplified Manual of Style

July 2014
Hello, I'm BracketBot. I have automatically detected that [//en.wikipedia.org/w/index.php?diff=616040627 your edit] to Pirfenidone may have broken the syntax by modifying 1 "<>"s. If you have, don't worry: just [ edit the page] again to fix it. If I misunderstood what happened, or if you have any questions, you can leave a message on [//en.wikipedia.org/w/index.php?action=edit&preload=User:A930913/BBpreload&editintro=User:A930913/BBeditintro&minor=&title=User_talk:A930913&preloadtitle=BracketBot%20–%20&section=new my operator's talk page].
 * List of unpaired brackets remaining on the page:

It's OK to remove this message. Also, to stop receiving these messages, follow these opt-out instructions. Thanks, BracketBot (talk) 04:26, 8 July 2014 (UTC)
 * by change in percent predicted forced vital capacity (FVC) from Baseline to Week 52 (rank ANCOVA p 0.000001). In addition, significant treatment effects were shown on both of the key secondary
 * | title = Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) | work = NCT01366209  | publisher = U.S. National Institutes of Health: ClinicalTrials.gov }}